Helsinn

Views & Analysis

Swiss cancer care company Helsinn has become unique in the industry by remaining a family business over three generations.

Oncology

Luke Piggot, a principal scientist at Debiopharm, shares some recent data and news about the company's work in DNA damage repair inhibitors.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.